Antonio Portolés

2.0k total citations
82 papers, 600 citations indexed

About

Antonio Portolés is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Antonio Portolés has authored 82 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Antonio Portolés's work include Immune Response and Inflammation (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmaceutical studies and practices (6 papers). Antonio Portolés is often cited by papers focused on Immune Response and Inflammation (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmaceutical studies and practices (6 papers). Antonio Portolés collaborates with scholars based in Spain, France and Netherlands. Antonio Portolés's co-authors include Emilio Vargas, José María Rojo, Isabel Barasoaı́n, Aitana Calvo, G. Resplandy, Leonor Laredo, Rafael López Núñez, Alexander Tomasz, C Ronda and Ignacio Martínez and has published in prestigious journals such as Nature, The Journal of Immunology and Journal of Virology.

In The Last Decade

Antonio Portolés

70 papers receiving 515 citations

Peers

Countries citing papers authored by Antonio Portolés

Since Specialization

Citations

This map shows the geographic impact of Antonio Portolés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Portolés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Portolés more than expected).

Fields of papers citing papers by Antonio Portolés

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Portolés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Portolés. The network helps show where Antonio Portolés may publish in the future.

Co-authorship network of co-authors of Antonio Portolés

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Portolés. A scholar is included among the top collaborators of Antonio Portolés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Portolés. Antonio Portolés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia 2025 ·JAMA Network Open ·(unknown), María Nieves Cabrera‐Martín, Cristina Delgado‐Alonso, Paz Suárez‐Coalla, Stephanie M. Grasso, Antonio Portolés, Natalia Pérez-Macías, (unknown), María Díez‐Cirarda, (unknown), Javier Olazarán, (unknown), (unknown), (unknown), Jorge Matías‐Guiu, Jordi A. Matías‐Guiu	1
2	Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial 2025 ·Pharmaceuticals ·Ana Ascaso, (unknown), Inmaculada Gilaberte, (unknown), Leonor Laredo, (unknown), (unknown), (unknown), (unknown), Carla Pérez-Ingidua, Emilio Vargas, Antonio Portolés	0
3	A scoping review of placebo and nocebo responses and effects: insights for clinical trials and practice 2025 ·Health Psychology Review ·Arianna Bagnis, (unknown), (unknown), Mary O’Keeffe, Elżbieta A. Bajcar, Przemysław Bąbel, Andrea W.M. Evers, (unknown), Marek Oleszczyk, Antonio Portolés, Johan W.S. Vlaeyen, Katia Mattarozzi, (unknown)	3
4	Intravenous vs. Oral Dose Comparison of Ibuprofen and Tramadol Combinations—Enantiomers, Metabolite, Linearity, and Sex-Related Effects: A Pharmacokinetics Randomized Clinical Trial 2025 ·Pharmaceuticals ·(unknown), (unknown), Ana Ascaso, (unknown), Leonor Laredo, (unknown), N. Sanz, Annik Bergeron, (unknown), Emilio Vargas, Antonio Portolés	0
5	Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial 2024 ·BMJ Open ·Jordi A. Matías‐Guiu, Javier J. González-Rosa, (unknown), María Luisa Martínez‐Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito‐León, Iván Padrón, (unknown), Jorge Matías‐Guiu	2
6	Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units 2023 ·Clinical and Translational Science ·(unknown), (unknown), Almari Conradie, (unknown), (unknown), (unknown), Uwe Fuhr, (unknown), Francisco Abad‐Santos, Antonio Portolés, (unknown), Antonio J. Carcas, Alberto M. Borobia	1
7	Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics 2022 ·Obesity Facts ·Antonio Portolés, A. Paterna, Andrés Sánchez Pernaute, Antonio Torres García, Carmen Moreno Lopera, (unknown), Fernando Bandrés, Amanda López Picado, Miguel A. Rubio, Emilio Vargas	5
8	Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study 2022 ·EClinicalMedicine ·Ana Ascaso, Javier García‐Pérez, Mayte Pérez‐Olmeda, Eunate Arana‐Arri, Itziar Vergara, Carla Pérez-Ingidua, Mercedes Bermejo, María Castillo de la Osa, Natale Imaz-Ayo, (unknown), (unknown), Francisco Díez‐Fuertes, Susana Meijide, Julio Arrizabalaga, (unknown), Erick De La Torre Tarazona, Alberto Lázaro, Emilio Vargas, José Alcamı́, Antonio Portolés	4
9	Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen 2020 ·Chirality ·Esperanza González‐Rojano, (unknown), Leonor Laredo, (unknown), John Gordon, Antonio Portolés, Emilio Vargas, Susana Morales‐Alcelay, Alfredo García‐Arieta	4
10	Rational Design, Structure–Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants 2019 ·Molecular Nutrition & Food Research ·(unknown), (unknown), M. Steiner, Josef Laimer, Bettina M. Jensen, Serge A. Versteeg, (unknown), Peter Briza, Laurian Zuidmeer, Neil M. Rigby, Juan A. Asturias, Antonio Portolés, Montserrat Fernández‐Rivas, Nikolaos G. Papadopoulos, Adriano Mari, Lars K. Poulsen, Peter Lackner, Ronald van Ree, Fátima Ferreira, Gabriele Gadermaier	14
11	European survey on national training activities in clinical research 2019 ·Trials ·(unknown), Valentina Cabral Iversen, G. Calvo, (unknown), Ola Dale, Regina Demlová, (unknown), (unknown), Gábor L. Kovaćs, Claire Lévy‐Marchal, Emília C. Monteiro, Lucia Palmisano, Daniel Pella, Antonio Portolés, Olivier Rascol, Caecilia Schmid, Fabian Tay, Heiko von der Leyen, Christian Ohmann	8
12	Estudio piloto de utilización de antifúngicos sistémicos en el Hospital Clínico San Carlos. Propuesta de un nuevo método de estudio 2009 ·Revista española de quimioterapia. Suplemento ·Sandrine Alonso, A Arribi, (unknown), (unknown), (unknown), (unknown), Antonio Portolés	3
13	Evaluación de costes sanitarios relacionados con el tratamiento con teicoplanina frente a vancomicina en las infecciones por grampositivos 2006 ·Revista española de quimioterapia. Suplemento ·Antonio Portolés, Juan José Picazo de la Garza, (unknown), (unknown), Miguel Puerro	4
14	Lack of Pharmacokinetic Interaction Between Omeprazole or Lansoprazole and Ivabradine in Healthy Volunteers: An Open‐Label, Randomized, Crossover, Pharmacokinetic Interaction Clinical Trial 2006 ·The Journal of Clinical Pharmacology ·Antonio Portolés, Aitana Calvo, (unknown), Leonor Laredo, G. Resplandy, (unknown), (unknown)	31
15	Effects of Hypericum perforatum on Ivabradine Pharmacokinetics in Healthy Volunteers: An Open‐Label, Pharmacokinetic Interaction Clinical Trial 2006 ·The Journal of Clinical Pharmacology ·Antonio Portolés, (unknown), Aitana Calvo, Ignacio Martínez, G. Resplandy	43
16	Physical dependence to morphine diminishes the interferon response in mice 1987 ·Immunopharmacology ·Pedro Lorenzo, (unknown), Antonio Portolés, (unknown), (unknown), (unknown)	17
17	Inmunoferon (Am3) Enhances the Activities of Early–Type Interferon Inducers and Natural Killer Cells. 1987 ·Immunopharmacology and Immunotoxicology ·Pilar Moya, Elena Baixerás, Isabel Barasoaı́n, José María Rojo, (unknown), (unknown), Antonio Portolés	13
18	[Proliferative response of murine lymphocytes caused by the activity of amphiphilic molecules from Propionibacterium acnes]. 1985 ·PubMed ·(unknown), (unknown), (unknown), Elena Góméz, Antonio Portolés	1
19	Indomethacin esters acting as anti-inflammatory and immunosuppressive drugs. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Isabel Barasoaı́n, José María Rojo, Carlos Sunkel, Antonio Portolés	6
20	Penicillin immunogenicity in the presence of different pharmaceutical adjuvants. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Antonio Portolés, (unknown), Fernanda F. Ramos, Rocío López, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact